IT8319219A0 - Derivati di arilossipropanolamina, procedimento per la loro preparazione composizioni farmaceutiche cheli contengono e loro impiego terapeutico - Google Patents

Derivati di arilossipropanolamina, procedimento per la loro preparazione composizioni farmaceutiche cheli contengono e loro impiego terapeutico

Info

Publication number
IT8319219A0
IT8319219A0 IT8319219A IT1921983A IT8319219A0 IT 8319219 A0 IT8319219 A0 IT 8319219A0 IT 8319219 A IT8319219 A IT 8319219A IT 1921983 A IT1921983 A IT 1921983A IT 8319219 A0 IT8319219 A0 IT 8319219A0
Authority
IT
Italy
Prior art keywords
procedure
contain
preparation
pharmaceutical compositions
therapeutic use
Prior art date
Application number
IT8319219A
Other languages
English (en)
Other versions
IT1193608B (it
Inventor
Cesare Casagrande
Massimo Nicola
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Priority to IT19219/83A priority Critical patent/IT1193608B/it
Publication of IT8319219A0 publication Critical patent/IT8319219A0/it
Priority to EP84100085A priority patent/EP0116825B1/en
Priority to DE8484100085T priority patent/DE3468104D1/de
Priority to AT84100085T priority patent/ATE31410T1/de
Priority to US06/568,598 priority patent/US4579861A/en
Priority to JP59009393A priority patent/JPS59139362A/ja
Application granted granted Critical
Publication of IT1193608B publication Critical patent/IT1193608B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT19219/83A 1983-01-21 1983-01-21 Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico IT1193608B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT19219/83A IT1193608B (it) 1983-01-21 1983-01-21 Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
EP84100085A EP0116825B1 (en) 1983-01-21 1984-01-06 New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
DE8484100085T DE3468104D1 (en) 1983-01-21 1984-01-06 New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
AT84100085T ATE31410T1 (de) 1983-01-21 1984-01-06 Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung.
US06/568,598 US4579861A (en) 1983-01-21 1984-01-06 Aryloxypropanolamine derivatives, pharmaceutical compositions and adrenegic thereof
JP59009393A JPS59139362A (ja) 1983-01-21 1984-01-20 アリ−ルオキシプロパノ−ルアミン誘導体，その製法およびそれを有効成分とする医薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19219/83A IT1193608B (it) 1983-01-21 1983-01-21 Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico

Publications (2)

Publication Number Publication Date
IT8319219A0 true IT8319219A0 (it) 1983-01-21
IT1193608B IT1193608B (it) 1988-07-21

Family

ID=11155887

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19219/83A IT1193608B (it) 1983-01-21 1983-01-21 Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico

Country Status (6)

Country Link
US (1) US4579861A (it)
EP (1) EP0116825B1 (it)
JP (1) JPS59139362A (it)
AT (1) ATE31410T1 (it)
DE (1) DE3468104D1 (it)
IT (1) IT1193608B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135487A (en) 2000-04-05 2005-07-25 Cupron Corp Antimicrobial and antiviral polymeric materials and a process for preparing the same
US7296690B2 (en) 2002-04-18 2007-11-20 The Cupron Corporation Method and device for inactivating viruses
US7364756B2 (en) 2003-08-28 2008-04-29 The Cuprin Corporation Anti-virus hydrophilic polymeric material
US7480393B2 (en) 2003-11-19 2009-01-20 Digimarc Corporation Optimized digital watermarking functions for streaming data
KR101254818B1 (ko) 2004-11-09 2013-04-15 쿠프론 인코포레이티드 피부 보호 방법 및 물질
WO2011115763A1 (en) * 2010-03-15 2011-09-22 The Trustees Of The University Of Pennsylvania Inhibitors of the tumor necrosis factor receptor complex
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DK193181A (da) * 1980-06-05 1981-12-06 Hoffmann La Roche Fremgangmaade til fremstilling af imidazolderivater
US4319032A (en) * 1980-06-06 1982-03-09 Alcolac Inc. Derivatives of aminoalkyl alkylene ureas

Also Published As

Publication number Publication date
EP0116825B1 (en) 1987-12-16
DE3468104D1 (en) 1988-01-28
JPS59139362A (ja) 1984-08-10
US4579861A (en) 1986-04-01
EP0116825A1 (en) 1984-08-29
IT1193608B (it) 1988-07-21
ATE31410T1 (de) 1988-01-15

Similar Documents

Publication Publication Date Title
IT1170286B (it) Derivati del labdano, procedimento per la loro preparazione, e composizioni farmaceutiche contenenti derivati del labdano
IT8767158A0 (it) Derivati benzofuranici procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che li comprendono
IT1205665B (it) Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1195267B (it) Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1200944B (it) Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
IT8319219A0 (it) Derivati di arilossipropanolamina, procedimento per la loro preparazione composizioni farmaceutiche cheli contengono e loro impiego terapeutico
IT1177485B (it) Composizioni farmaceutiche antitumorali e procedimento per la loro preparazione
IT1193590B (it) Derivati amino-alchil-solfonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8667976A0 (it) Derivati teofillinmetilditiolanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
IT9021305A0 (it) Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
IT8522327A0 (it) Derivati macromolecolarizzati di cdp-colina, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT1168766B (it) Derivati di piperazina e di omopipe razina,procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1218322B (it) Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
IT1201497B (it) Derivati tienopiridinici,procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT1228130B (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
IT1235761B (it) Derivati biciclici del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono
IT8922275A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1208533B (it) Derivati di apovincaminolo, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1172268B (it) Piperidinoguanidine sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8747852A0 (it) Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8622783A0 (it) Derivati imidazolici adattivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1214729B (it) Derivati di acido tiofenacetico,procedimento per la loro preparazione, composizioni farmaceutiche che licontengono e loro impiego come medicamenti
IT1210868B (it) Derivati della cefuroxima attivi per via orale procedimenti per laloro preparazione e relative composizioni farmaceutuche.
IT1190931B (it) Derivati di acidi biliari,procedimento per la loro preparazione e relative composizioni farmaceutiche